UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 9, pp. 875 - 881
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drugs | Medical law | Care and treatment | Children | Pediatric research | Laws, regulations and rules | Hypertension | Prescription drugs | Pediatrics | Descriptive labeling | Legislation | Clinical trials | FDA approval | Drug development | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 627 - 635
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dose-prediction | Pharmacodynamic-modelling | Population-pharmacokinetics | Product-approvals | Clinical-trial-design | Labelling | Pharmacokinetic-pharmacodynamic-relationships | Pharmacokinetic-modelling | Regulatory-process | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions | United States | Humans | Decision Support Techniques | Drugs, Investigational - pharmacokinetics | Drug Labeling - statistics & numerical data | Clinical Trials as Topic | Drug Labeling - standards | Dose-Response Relationship, Drug | Drug Labeling - legislation & jurisprudence | Models, Biological | Investigational New Drug Application - legislation & jurisprudence | Drugs, Investigational - administration & dosage | Investigational New Drug Application - statistics & numerical data | Investigational New Drug Application - methods | Drug Labeling - methods | United States Food and Drug Administration | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 103 - 105
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | State Government | Local Government | Time Factors | United States | Food Labeling - legislation & jurisprudence | Government Regulation | Lobbying | Public Health - legislation & jurisprudence | Energy Intake | Patient Protection and Affordable Care Act | United States Food and Drug Administration | Laws, regulations and rules | Food industry | Food labeling | Retail stores | Obesity | Health care policy | Consumers | Federal regulation | Public interest | Disclosure | Restaurants | Local elections | Pizza | Enforcement | Government agencies | Price, Tom | Food chains | Gottlieb, Scott | Labeling | Public health | Food | Smoking | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2003, Volume 290, Issue 7, pp. 905 - 911
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | Medical sciences | Pharmaceutical industries | United States | Humans | Child, Preschool | Infant | Treatment Outcome | Drug Labeling - standards | Drug Labeling - legislation & jurisprudence | Drug Therapy - standards | Adolescent | Pediatrics - standards | Safety | Child | Infant, Newborn | Marketing - legislation & jurisprudence | United States Food and Drug Administration | Pediatric pharmacology | Laws, regulations and rules | Drugs | Labeling | Federal regulation | Index Medicus | Abridged Index Medicus
Journal Article
JAMA pediatrics, ISSN 2168-6203, 12/2013, Volume 168, Issue 2, pp. 130 - 136
Life Sciences & Biomedicine | Pediatrics | Science & Technology | Infant, Newborn, Diseases - drug therapy | Drug Labeling - legislation & jurisprudence | United States - epidemiology | Intensive Care Units, Neonatal | Humans | Drug Labeling - statistics & numerical data | Infant, Newborn | United States Food and Drug Administration | Patient package inserts | Infants | Information management | Health aspects | Index Medicus | Abridged Index Medicus | FDA | neonate | drugs | labeling | medications
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2010, Volume 362, Issue 25, pp. 2343 - 2345
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Health Care Reform | Food Labeling - standards | Nutritive Value | United States | Humans | Obesity - prevention & control | Food Labeling - legislation & jurisprudence | Energy Intake | Restaurants - legislation & jurisprudence | United States Food and Drug Administration | Restaurants - standards | Prevention | Obesity | Control | Laws, regulations and rules | Chain restaurants | Health care reform | Food labeling | Stores | Studies | Descriptive labeling | Diet | Nutrition | Health care policy | Public interest | Labeling | Restaurants | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 193 - 195
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Nutrition Policy - legislation & jurisprudence | Food Labeling - standards | Nutritive Value | United States | Humans | Food Labeling - legislation & jurisprudence | United States Food and Drug Administration | Natural foods | Obesity | Control | Food labeling | Analysis | Standards | Consumer behavior | Descriptive labeling | Nutrition | Proposals | Sugar | Food | Index Medicus | Abridged Index Medicus
Journal Article
Pharmacoepidemiology and drug safety, ISSN 1053-8569, 03/2013, Volume 22, Issue 3, pp. 294 - 301
drug labeling | generic medications | adverse reactions | drug safety | pharmacoepidemiology | Pharmacoepidemiology | Generic medications | Adverse reactions | Drug safety | Drug labeling | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | General pharmacology | Clinical trial. Drug monitoring | Pharmacology. Drug treatments | Adverse Drug Reaction Reporting Systems - legislation & jurisprudence | Guidelines as Topic | Adverse Drug Reaction Reporting Systems - standards | Risk Assessment | United States | Drug Industry - legislation & jurisprudence | Humans | Risk Factors | United States Food and Drug Administration - standards | Natural Language Processing | Drug Labeling - standards | United States Food and Drug Administration - legislation & jurisprudence | Drug Labeling - legislation & jurisprudence | Drugs, Generic - adverse effects | Guideline Adherence | Patient Safety | Drug and Narcotic Control - legislation & jurisprudence | Drug Industry - standards | Therapeutic Equivalency | Drugs | Labels | Structured notes (Securities) | Analysis | Prescription drugs | Federal regulation | Descriptive labeling | Safety | Index Medicus
Journal Article
Trends in biotechnology (Regular ed.), ISSN 0167-7799, 2016, Volume 35, Issue 1, pp. 1 - 3
Internal Medicine | GM foods | mandatory labeling | food value chain | Mandatory labeling | Food value chain | Consumer Product Safety - legislation & jurisprudence | Food Labeling - standards | Public Opinion | United States | Consumer Product Safety - standards | Food Labeling - legislation & jurisprudence | Government Regulation | Food, Genetically Modified - standards | United States Food and Drug Administration | Biotechnology | Genetically engineered foods | Genetically modified organisms | Food | Food labeling | Consumption | Descriptive labeling | Cost estimates | Value chain | Consumers | Ingredients | Science | Federal legislation | Deoxyribonucleic acid--DNA | Index Medicus | Legislation | Chromium | Labels | Foods | Trends | Standards | Genetic modification
Journal Article
Alternatives to laboratory animals, ISSN 0261-1929, 09/2011, Volume 39, Issue 4, pp. 339 - 364
REACH | Validation | EpiOcular | ECVAM | Reconstructed ocular tissue model | In vitro | Eye irritation | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Biological and medical sciences | Toxicology | Medical sciences | Domestic and cosmetic products toxicology | Product Labeling | Animal Testing Alternatives | Humans | Cosmetics | Toxicity Tests - methods | Eye - drug effects | Irritants - toxicity | Quality Control | Index Medicus
Journal Article
Indian journal of medical ethics, 07/2017, Volume 2, Issue 3, pp. 194 - 199
Biomedical Research - ethics | United States | Deception | Humans | Randomized Controlled Trials as Topic - ethics | Randomized Controlled Trials as Topic - legislation & jurisprudence | Publishing - legislation & jurisprudence | Fraud | Disclosure | Evidence-Based Medicine | Ethics, Research | United States Food and Drug Administration - legislation & jurisprudence | Biomedical Research - legislation & jurisprudence | United States Food and Drug Administration - ethics | Legislation, Medical | Editorial Policies | Government Regulation | Publishing - ethics | Research Report - legislation & jurisprudence | Ethical Theory
Journal Article
Nicotine & tobacco research, ISSN 1462-2203, 2012, Volume 14, Issue 1, pp. 62 - 74
Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | United States | Humans | Product Packaging - legislation & jurisprudence | Product Packaging - standards | Smoking - legislation & jurisprudence | Disclosure - legislation & jurisprudence | Research | Smoking Prevention | Tobacco | Tobacco Industry - economics | Drug and Narcotic Control - legislation & jurisprudence | Government Regulation | Tobacco Industry - legislation & jurisprudence | Consumer Health Information | Disclosure - standards | United States Food and Drug Administration | Index Medicus | Themed Section
Journal Article
Nicotine & tobacco research, ISSN 1462-2203, 02/2016, Volume 18, Issue 2, pp. 221 - 226
Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Commerce - economics | United States - epidemiology | Advertising as Topic - economics | Advertising as Topic - legislation & jurisprudence | Cross-Sectional Studies | Humans | Male | Smoking - legislation & jurisprudence | Product Labeling - economics | Taxes - legislation & jurisprudence | United States Food and Drug Administration - legislation & jurisprudence | Product Labeling - legislation & jurisprudence | Tobacco Industry - economics | Smoking - epidemiology | Tobacco Products - economics | Adolescent | Female | Tobacco Industry - legislation & jurisprudence | Marketing - economics | Marketing - legislation & jurisprudence | Taxes - economics | Commerce - legislation & jurisprudence | Index Medicus | Brief Report
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 02/2007, Volume 81, Issue 2, pp. 213 - 221
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Drug Evaluation - methods | Lipoproteins - therapeutic use | Quinoxalines - adverse effects | Risk Assessment - methods | United States | Benzazepines - adverse effects | Humans | United States Food and Drug Administration - standards | Varenicline | Cyclosporins - administration & dosage | Data Collection | Peptides, Cyclic - administration & dosage | United States Food and Drug Administration - legislation & jurisprudence | Drug Labeling - legislation & jurisprudence | Cyclosporins - therapeutic use | Investigational New Drug Application - legislation & jurisprudence | Everolimus | Sirolimus - adverse effects | Lipoproteins - adverse effects | Quinoxalines - therapeutic use | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Drug Administration Schedule | Peer Review | Quinoxalines - administration & dosage | Cyclosporins - adverse effects | Decision Support Techniques | Pharmacology, Clinical | Treatment Outcome | Disease Progression | Drug Approval - legislation & jurisprudence | Sirolimus - administration & dosage | Lipoproteins - administration & dosage | Benzazepines - therapeutic use | Echinocandins | Investigational New Drug Application - statistics & numerical data | Peptides, Cyclic - therapeutic use | Benzazepines - administration & dosage | Clinical Trials as Topic - methods | Pharmacokinetics | Lipopeptides | Peptides, Cyclic - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article